special-reports fierce-healthcares-fierce-15-2023 
ISPE
SEPTEMBER 11, 2023
Considerations for a Decentralized Manufacturing Paradigm Trudy Patterson Mon, 09/11/2023 - 06:47 Features September / October 2023 Considerations for a Decentralized Manufacturing Paradigm Marquerita Algorri, PhD Ting Wang, PhD Jocelyn X. 7 June 2023. Fierce Pharma. Accessed 14 April 2023. McQueen Nina S.
ISPE
JULY 6, 2023
As of 2022, there were 15 drugs (see Table 1) manufactured using CM elements that have received FDA approval, with GSK, Pfizer, and Vertex owning approximately 60% of the market share, followed by Janssen/J&J with about 13%. Pharma Investment Trend Report: What We’re Watching in 2023.” Published 13 January 2023.
Expert insights. Personalized for you.
52 
Let's personalize your content